Although the hallmark of ILC1 is their ability to produce IFN-γ, a CD49ahi ILC1-like population, capable of lysing tumor cells, has been described by Dadi et al. in mouse mammary tumors expressing granzyme B and TNF-related apoptosis-inducing ligand and intermediate levels of Eomes (24). Here, IFNG is linked to neoplasm.